Avalon-GSK Partnership to Welcome 2 More Cos. to the World
Friday, May 30, 2014
I have the hazy outlines of a scoop for you, my dear readers:
Two more companies have been born out of Avalon Ventures’ unconventional, $495 million alliance with British pharma giant GlaxoSmithKline PLC, according to Douglas Downs, a managing partner and chief financial officer at Avalon Ventures...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know